Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search


Verily is developing tools and platforms to enable more continuous health data collection for timely decision-making and effective interventions. They are running longitudinal studies to better understand ways to predict and prevent disease onset and progression.

Verily has a mission to make the world’s health data useful to allow people to live longer healthier lives. The company develops tools and devices to collect, organize and activate health data and interventions to prevent and manage disease. Verily partners with partners in life sciences, medical device and government organizations.

Verily is a subsidiary of Alphabet, which is also the parent company of Google. Verily is overseeing plans for a website to help Americans find screening tests for the COVID-19 coronavirus. The project, which will direct people to drive through clinics popping up in parking lots of stores like Target and Walmart, will initially be available to residents in the San Francisco and Silicon Valley area. On March 13, 2020, Verily stated they were in the early stages of developing the tool.


August 5, 2021
Verily launches AI research center in Israel, picks up Google Health projects.
December 17, 2020
Verily raises a $700 million round from its current investors, including Google parent Alphabet, Silver Lake, Temasek, Ontario Teachers' Pension Plan and others.
January 2019
Verily raises a $1,000,000,000 venture round from Ontario Teachers' Pension Plan and Silver Lake Partners.
Verily receives an $800-million investment from Singapore's Temasek.
Verily was launched.

Funding Rounds

Invested in


Funding Rounds Participated In

Further Resources



Heather Landi
September 30, 2021
Verily's Onduo is teaming up with Google-owned Fitbit to provide wearable devices to support members' chronic condition management and overall health and wellness. It marks the first official collaboration between Onduo, a virtual clinic housed within Alphabet's life sciences arm Verily, with wearable giant Fitbit, which Google officially acquired in January.
Heather Landi
August 26, 2021
Alphabet's Verily continues to push further into clinical care and is using its tech muscle to build advanced decision support tools for providers. Teaming up with Mayo Clinic, Verily will pull in the hospital's clinical content and apply advanced clinical analytics and user-centered design to deliver care insights with an initial focus on cardiovascular and cardiometabolic conditions.
Josh Scott
June 18, 2021
San-Francisco medical device company Verily plans to open a new site dedicated to engineering, data science, and product development in Kitchener-Waterloo.
Heather Landi
June 11, 2021
Verily's recent hiring of former FDA official Amy Abernethy, M.D., Ph.D., signals it has strong ambitions to transform research to make it easier and faster to run clinical trials. Abernethy recently chatted with Fierce Healthcare about her move to the Alphabet life sciences venture and her vision to grow the company's clinical research business.
Andrea Park
June 3, 2021
Amy Abernethy joins Verily shortly after her sudden departure from the FDA, where she had served as principal deputy commissioner of food and drugs for a little over two years--and where she was widely seen as a top contender for the agency's (still-unfilled) top commissioner post.


Golden logo
By using this site, you agree to our Terms & Conditions.